Fascin is involved in the chemotherapeutic resistance of breast cancer cells predominantly via the PI3K/Akt pathway von Ghebeh, H, Al-Khaldi, S, Olabi, S, Al-Dhfyan, A, Al-Mohanna, F, Barnawi, R, Tulbah, A, Al-Tweigeri, T, Ajarim, D, Al-Alwan, M

Volltext

The safety and efficacy of durvalumab in combination with paclitaxel for the treatment of metastatic triple negative breast cancer von Ghebeh, H., Alsayed, A.N., Suleman, K., Al-Tweigeri, T.

Volltext

Retrospective review of Her2 positive metastatic breast cancer patients who received Pertuzumab and Herceptin as a first line therapy at KFSH&RC (single institute experience) from... von Suleman, K., Mushtaq, A., Haque, E., Badran, A., Ajarim, D., Tweigeri, T., Elashwah, A., Shahin, A., Khan, K., Alsayed, A.

Volltext

Phase II Study of Docetaxel, Doxorubicin, and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer von NABHOLTZ, J. M, MACKEY, J. R, SMYLIE, M, PATERSON, A, NOËL, D. R, AL-TWEIGERI, T, TONKIN, K, NORTH, S, AZLI, N, RIVA, A

Volltext

1236TiPThe safety and efficacy of durvalumab in combination with paclitaxel for the treatment of metastatic triple negative breast cancer von Ghebeh, H, Alsayed, A N, Suleman, K, Al-Tweigeri, T

Volltext

Durvalumab and paclitaxel combination for treatment of metastatic triple negative breast cancer is safe with very promising efficacy von Ghebeh, H., AlSayed, A., Suleman, K., Ajarim, D., Cabangon, L., Tulbah, A., Al-Tweigeri, T.

Volltext

1273P - Durvalumab and paclitaxel combination for treatment of metastatic triple negative breast cancer is safe with very promising efficacy von Ghebeh, H., AlSayed, A., Suleman, K., Ajarim, D., Cabangon, L., Tulbah, A., Al-Tweigeri, T.

Volltext

1273PDurvalumab and paclitaxel combination for treatment of metastatic triple negative breast cancer is safe with very promising efficacy von Ghebeh, H, AlSayed, A, Suleman, K, Ajarim, D, Cabangon, L, Tulbah, A, Al-Tweigeri, T

Volltext

Adjuvant Docetaxel for Node-Positive Breast Cancer von Martin, Miguel, Pienkowski, Tadeusz, Mackey, John, Pawlicki, Marek, Guastalla, Jean-Paul, Weaver, Charles, Tomiak, Eva, Al-Tweigeri, Taher, Chap, Linnea, Juhos, Eva, Guevin, Raymond, Howell, Anthony, Fornander, Tommy, Hainsworth, John, Coleman, Robert, Vinholes, Jeferson, Modiano, Manuel, Pinter, Tamas, Tang, Shou C, Colwell, Bruce, Prady, Catherine, Provencher, Louise, Walde, David, Rodriguez-Lescure, Alvaro, Hugh, Judith, Loret, Camille, Rupin, Matthieu, Blitz, Sandra, Jacobs, Philip, Murawsky, Michael, Riva, Alessandro, Vogel, Charles

Volltext

264P Neutrophil-to-lymphocyte ratio as a prognostic factor for neoadjuvant chemotherapy for locally advanced breast cancer von Alshamsan, B., Aseafan, M.J., Fahmy, N., A. badran, Elhassan, T., Elshenawy, M.A., Alsayed, A., Suleman, K., Ajarim, D.S., Al-Tweigeri, T.

Volltext

Association Between Obesity and Clinicopathological Profile of Patients with Newly Diagnosed Non-Metastatic Breast Cancer in Saudi Arabia von Alshamsan, Bader, Suleman, Kausar, Agha, Naela, Abdelgawad, Marwa I, Alzahrani, Mashari J, Elhassan, Tusneem, Al-Tweigeri, Taher, Ajarim, Dahish, Alsayed, Adher

Volltext

P144 - Retrospective review of Her2 positive metastatic breast cancer patients who received Pertuzumab and Herceptin as a first line therapy at KFSH&RC (single institute experience... von Suleman, K., Mushtaq, A., Haque, E., Badran, A., Ajarim, D., Tweigeri, T., Elashwah, A., Shahin, A., Khan, K., Alsayed, A.

Volltext

PCN60 - Financial Impact of Introducing Sc Trastuzumab (HERCEPTIN) Versus Currently Used IV Trastuzumab (HERCEPTIN) on The Budgets of Different Hospitals Across Kingdom of Saudi Ar... von A, N, Ali, A, AL-Tweigeri, T, Zekri, J, Awad, N, Safwat, M, Narang, A, Goyal, R

Volltext

Financial Impact of Introducing Sc Trastuzumab (HERCEPTIN) Versus Currently Used IV Trastuzumab (HERCEPTIN) on The Budgets of Different Hospitals Across Kingdom of Saudi Arabia (KS... von A, N, Ali, A, AL-Tweigeri, T, Zekri, J, Awad, N, Safwat, M, Narang, A, Goyal, R

Volltext

Soft tissue malignant lymphoma at sites of previous surgery von Radhi, J M, Ibrahiem, K, al-Tweigeri, T

Volltext

Association Between Neutrophil-Lymphocyte Ratio and Oncotype Dx Recurrence Score in Early-Stage Hormonal Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer von Alshamsan, Bader, Alshibany, Aisha, Elshenawy, Mahmoud A, Badran, Ahmed, Elhassan, Tusneem, Ajarim, Dahish, Alsayed, Adher, Suleman, Kausar, Al-Tweigeri, Taher

Volltext

Analysis of the relationship between chimerism and the allogeneic humoral response von OKASHA, K. M, AL-TWEIGERI, T. A, JURADO, A. V, SHOKER, A. S

Volltext

p16 super(INK4A) Represses Breast Stromal Fibroblasts Migration/Invasion and Their VEGF-A-dependent Promotion of Angiogenesis through Akt Inhibition von Al-Ansari, M M, Hendrayani, S-F, Tulbah, A, Al-Tweigeri, T, Shehata, AI, Aboussekhra, A

Volltext

Abstract P4-05-02: Role of the Atr Protein Kinase and Curcumin in Tumor-Stromal Interactions in Breast Cancer von Aboussekhra, A, Al-Ansari, MM, Hendrayani, S-F, Al-Tweigeri, T.

Volltext

Breast cancer in the Kingdom of Saudi Arabia: A review of all female breast cancer cases from the Saudi Cancer Registry (SCR) from 1994-2004 von Al Sayed, A. D., Shoukri, M., Al-Eid, H., Al-Tweigeri, T., Al-Dalee, A., Al-Shabanah, M., Al-Malik, O., Ezzat, A. A., Ajarim, D. S., Bazarbashi, S.

Volltext